Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 502

1.

A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

Plank J, Wutte A, Brunner G, Siebenhofer A, Semlitsch B, Sommer R, Hirschberger S, Pieber TR.

Diabetes Care. 2002 Nov;25(11):2053-7.

PMID:
12401756
3.
4.
5.

Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type 2 diabetes.

Hermansen K, Colombo M, Storgaard H, ØStergaard A, Kølendorf K, Madsbad S.

Diabetes Care. 2002 May;25(5):883-8.

PMID:
11978685
6.

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus.

McSorley PT, Bell PM, Jacobsen LV, Kristensen A, Lindholm A.

Clin Ther. 2002 Apr;24(4):530-9.

PMID:
12017398
8.

Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.

Heinemann L, Heise T, Wahl LC, Trautmann ME, Ampudia J, Starke AA, Berger M.

Diabet Med. 1996 Jul;13(7):625-9.

PMID:
8840095
9.

Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs.

Lindström T, Hedman CA, Arnqvist HJ.

Diabetes Care. 2002 Jun;25(6):1049-54.

PMID:
12032113
10.

Postprandial insulin lispro. A new therapeutic option for type 1 diabetic patients.

Schernthaner G, Wein W, Sandholzer K, Equiluz-Bruck S, Bates PC, Birkett MA.

Diabetes Care. 1998 Apr;21(4):570-3.

PMID:
9571344
11.
12.

Impact of diabetic nephropathy on pharmacodynamic and Pharmacokinetic properties of insulin in type 1 diabetic patients.

Rave K, Heise T, Pfützner A, Heinemann L, Sawicki PT.

Diabetes Care. 2001 May;24(5):886-90.

PMID:
11347749
13.

Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.

Roach P, Bai S, Charbonnel B, Consoli A, Taboga C, Tiengo A, Bolli G; High Mix Study Group.

Clin Ther. 2004 Apr;26(4):502-10.

PMID:
15189747
14.
15.

Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects.

Homko C, Deluzio A, Jimenez C, Kolaczynski JW, Boden G.

Diabetes Care. 2003 Jul;26(7):2027-31.

PMID:
12832307
16.

Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size.

Jovanovic L, Giammattei J, Acquistapace M, Bornstein K, Sommermann E, Pettitt DJ.

Clin Ther. 2004 Sep;26(9):1492-7.

PMID:
15531011
17.

Improved postprandial glycemic control with Humalog Mix75/25 after a standard test meal in patients with type 2 diabetes mellitus.

Malone JK, Woodworth JR, Arora V, Yang H, Campaigne BN, Hallé JP, Yale JF, Grossman LD.

Clin Ther. 2000 Feb;22(2):222-30.

PMID:
10743981
18.

Efficacy of biphasic insulin aspart in patients with type 2 diabetes.

Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G.

Clin Ther. 2005;27 Suppl B:S57-74. Review.

PMID:
16519038
19.

Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial.

Perriello G, Pampanelli S, Porcellati F, Avogaro A, Bosi E, Petrella G, Squatrito S, Furneri S, Marra G, Vitali L, Previti M, Cucinotta D.

Diabet Med. 2005 May;22(5):606-11.

PMID:
15842516
20.

Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.

Ciofetta M, Lalli C, Del Sindaco P, Torlone E, Pampanelli S, Mauro L, Chiara DL, Brunetti P, Bolli GB.

Diabetes Care. 1999 May;22(5):795-800.

Supplemental Content

Support Center